ISRCTN57061725: The Scottish ePrEP Clinic Feasibility Study: Assessing the feasibility of providing HIV prevention medication online
- Overall study status
- Ongoing
- Recruitment status
- Recruiting
The Scottish ePrEP Clinic Feasibility Study
Using the ISRCTN registry to track transparency
The ISRCTN registry wants to encourage trialists to follow research openness and transparency recommendations.
Registry records now display badges to highlight prospective registration, regular updating of ongoing records and posting protocols, statistical analysis plans (SAPs), data links and results to the record. The BEEP trial is an example that has several of the badges.
The transparency tracker provides a visual display of the transparency achieved by a set of records, found by a search of the registry. For any search click on 'View in tracker' to view the results in the transparency tracker. Here is an example of the transparency tracker for a search where the condition category = Cancer.
Do you think these new features are useful? We are keen to know what you think. Please complete our feedback form.
The ISRCTN registry is a primary clinical study registry recognised by the World Health Organisation (WHO) and the International Committee of Medical Journal Editors (ICMJE) that accepts all clinical research studies (whether proposed, ongoing or completed), providing content validation and curation and the unique identification number necessary for publication. All study records in the database are freely accessible and searchable.
ISRCTN supports transparency in clinical research, helps reduce selective reporting of results and ensures an unbiased and complete evidence base.
The registry aims to include all interventional and non-interventional clinical studies that prospectively involve UK participants and evaluate biomedical or health-related outcomes.
Studies conducted outside the UK or considered to be non-clinical studies (e.g. public health studies) can be registered on ISRCTN.
Studies should ideally be registered prospectively (before recruitment starts). ISRCTN also accepts studies registered retrospectively once they are underway or after completion.
The Scottish ePrEP Clinic Feasibility Study
A phase II, multi-centre, open-label, randomised study to evaluate the anti-tumour activity of roginolisib in patients with advanced/metastatic ocular/uveal melanoma
Severe MAlaria A Research and Trials consortium: A protocol for a prospective observational study